Photo of Matt Gaetz
R United States House · District 1 · Former member · Florida

Rep. Matt Gaetz

Compare
Total votes
2,111
all sessions
Attendance
95%
114 missed
Lower than 90% of chamber peers
With party
80%
of cast votes
Lower than 94% of chamber peers
Bipartisan score
10%
some cross-party votes
Higher than 94% of chamber peers
Sponsored
1,056
bills & resolutions
Higher than 92% of chamber peers
Committees
0
assignments
1,056 bills and resolutions

Sponsored bills

Total
1,056
Primary
59
Co-sponsor
997
This page
1,056
matching current filters
Co-sponsor HR 2073
In committee · United States House · Co-sponsor
To provide for a limitation on availability of funds for Executive Office of the President, Office of National Drug Control Policy, Other Federal Drug Control Programs for fiscal year 2024.

Maddy summaryHR 2073 sets a spending limit of $118,327,000 for federal drug control programs in fiscal year 2024, including the Office of National Drug Control Policy and related initiatives. This bill directly affects funding for national drug control efforts by restricting available resources to this specific cap. The key provision is a statutory limit that overrides other funding authorizations for these programs during FY2024. It does not change drug policy or create new programs, but restricts the total funding available for existing federal drug control activities.

In committee Mar 29, 2023 1 co-sponsor
Co-sponsor HR 2072
In committee · United States House · Co-sponsor
To provide for a limitation on availability of funds for Executive Office of the President, Office of National Drug Control Policy, Federal Drug Control Programs, High Intensity Drug Trafficking Areas Program for fiscal year 2024.

Maddy summaryHR 2072 sets a spending cap of $280 million for specific federal drug control programs in fiscal year 2024. It directly limits funding for the Executive Office of the President's drug policy functions, the Office of National Drug Control Policy, Federal Drug Control Programs, and High Intensity Drug Trafficking Areas Program. The bill prevents these programs from using more than $280 million in available funds for FY2024. This is a direct budgetary restriction on federal drug control initiatives.

In committee Mar 29, 2023 1 co-sponsor
Co-sponsor HR 2007
In committee Mar 29, 2023 1 co-sponsor
Co-sponsor HR 2071
In committee · United States House · Co-sponsor
To provide for a limitation on availability of funds for Executive Office of the President, Office of National Drug Control Policy, Salaries and Expenses for fiscal year 2024.

Maddy summaryHR 2071 limits funding for the Office of National Drug Control Policy (ONDCP) within the Executive Office of the President to $18.4 million for fiscal year 2024. This bill directly affects the ONDCP's budget for salaries and operations, capping its available funds at the specified amount. It does not alter drug policy or create new programs, but instead enforces a strict spending restriction on the office's existing budget authority. The provision applies to all funds authorized for the ONDCP's Salaries and Expenses account during FY2024.

In committee Mar 29, 2023 1 co-sponsor
Co-sponsor HR 2045
In committee · United States House · Co-sponsor
To provide for a limitation on availability of funds for Related Agencies, Occupational Safety and Health Review Commission for fiscal year 2024.

Maddy summaryThis bill caps annual funding for the Occupational Safety and Health Review Commission (OSHRC) and related agencies at $13.225 million for fiscal year 2024. It directly limits the available budget for these entities, preventing them from spending more than this specified amount. The provision is a straightforward budgetary restriction with no policy changes to workplace safety rules or programs. It applies solely to FY2024 funding authorization.

In committee Mar 29, 2023 1 co-sponsor
Co-sponsor HR 1993
In committee · United States House · Co-sponsor
To provide for a limitation on availability of funds for Department of Health and Human Services, National Institutes of Health National Institute of Biomedical Imaging and Bioengineering for fiscal year 2024.

Maddy summaryHR 1993 sets a strict funding cap of $389,464,000 for the National Institute of Biomedical Imaging and Bioengineering (NIBIB) within the National Institutes of Health (NIH) for fiscal year 2024. This bill directly affects the NIBIB by limiting its available budget to this specific amount, preventing it from using more funds authorized for that year. The key mechanism is a hard limit on appropriations, ensuring the NIBIB cannot exceed this dollar amount for its operations and research during FY2024. This is a budgetary restriction, not a policy change affecting public programs or services.

In committee Mar 29, 2023 1 co-sponsor
Co-sponsor HR 2082
In committee · United States House · Co-sponsor
To provide for a limitation on availability of funds for The Judiciary, Court of Appeals, District Courts, and Other Judicial Services, Salaries and Expenses for fiscal year 2024.

Maddy summaryHR 2082 sets a spending cap of $5.14 billion for federal judicial operations in fiscal year 2024, including salaries and expenses for the Court of Appeals, District Courts, and other judicial services. This bill directly limits available funding for all federal courts and judicial support services during the 2024 budget year. The key provision prevents any further appropriations or use of existing funds for these courts once the $5.14 billion threshold is reached. As a procedural budget measure, it does not alter court procedures or create new policies but strictly governs funding availability.

In committee Mar 29, 2023 1 co-sponsor
Co-sponsor HR 2056
In committee · United States House · Co-sponsor
To provide for a limitation on availability of funds for Department of Treasury, Bureau of the Fical Service, Salaries and Expenses for fiscal year 2024.

Maddy summaryHR 2056 sets a spending cap of $335,936,000 for the Treasury Department's Bureau of the Fiscal Service in fiscal year 2024, limiting available funds for its salaries and operations. This bill directly affects the Bureau's budget authority for FY2024 by restricting its spending to the specified amount. The key provision is a statutory limit on funds, preventing the Bureau from exceeding this total for its core administrative expenses.

In committee Mar 29, 2023 1 co-sponsor
Co-sponsor HR 2081
In committee · United States House · Co-sponsor
To provide for a limitation on availability of funds for The Judiciary, US Court of International Trade, Salaries and Expenses for fiscal year 2024.

Maddy summaryThis bill sets a spending limit of $18,882,000 for the Judiciary and the U.S. Court of International Trade's Salaries and Expenses account during fiscal year 2024. It directly affects these federal courts by restricting their available funding to this specific amount for salaries and operational expenses. The key provision is a statutory cap that overrides any other funding authorization, ensuring no more than $18.882 million is spent on these specific judicial functions for FY2024.

In committee Mar 29, 2023 1 co-sponsor
Co-sponsor HR 2055
In committee · United States House · Co-sponsor
To provide for a limitation on availability of funds for Department of Treasury, Financial Crimes Enforcement Network, Salaries and Expenses for fiscal year 2024.

Maddy summaryHR 2055 sets a spending cap of $117,800,000 for the Financial Crimes Enforcement Network (FinCEN), a unit within the Department of the Treasury, for fiscal year 2024. This bill directly limits the available funds for FinCEN's salaries and operations during that fiscal year. The provision prevents the agency from using more than this specific amount, regardless of other funding authorizations. This is a procedural budgetary measure affecting only FinCEN's FY2024 appropriations.

In committee Mar 29, 2023 1 co-sponsor
Showing 391 to 400 of 1,056 bills
Previous 1 … 39 40 41 … 106 Next